Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SNDXSNDX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in SYNDAX PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 5.9M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $128.1M as of 2026-Q2. The position was increased (+17.3% shares). SNDX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$128.1M

Current Shares

5.9M

Total Value Change

+$49.5M

Total Shares Change

-89,272

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.9M
+17.3%
$128.1M0.0%$21.86
35
2026-Q1
Decreased
5M
-12.3%
$116.7M0.0%$21.40
0
2025-Q4
Increased
5.7M
+3.8%
$119.7M0.0%$20.74
31
2025-Q3
Decreased
5.5M
-5.4%
$84.4M0.0%$15.56
0
2025-Q2
Increased
5.8M
+47.8%
$54.3M0.0%$9.04
40
2025-Q1
Decreased
3.9M
-34.1%
$48.2M0.0%$13.18
0
2024-Q4
New
6M
-
$78.7M0.0%$12.52
41

Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used